Access Medicines Beyond Borders
We specialize in Named Patient Supply, ensuring timely access to critical, life-saving medications that are not commercially available in your country. Partner with us to bring hope and health where it’s needed most.
An ISO 9001:2015 certified and WHO-GSDP compliant company.
What Is Named Patient Supply?
Named Patient Supply is a regulatory pathway that allows patients to access medicines not yet approved or commercially available in their country. At WPI Pharma, we partner with leading global manufacturers and health authorities to secure these critical therapies on a patient-by-patient basis.
Whether it’s an investigational oncology drug, a rare-disease biologic, or a specialized orphan therapy, our team handles all regulatory filings, quality checks, and logistics to bring you the treatment you need—fast and fully compliant.
How It Works
Our end-to-end Named Patient Supply service is designed to be transparent, efficient, and patient-centric. Here’s our six-step process:
Initial Consultation
You or your physician shares the patient’s medical history, diagnosis, and prescription.
Regulatory Assessment
We prepare and submit all necessary documentation to the local health authority.
Manufacturer Coordination
We liaise with approved global manufacturers to reserve and quality-test the batch.
Import-Export Clearance
Our logistics team secures all customs and import permits, including cold-chain.
Secure Delivery
We arrange temperature-controlled shipping directly to your clinic or hospital pharmacy.
Ongoing Support
Post-delivery, we provide pharmacovigilance reporting and handle regulatory queries.
Why Choose WPI Pharma?
Deep Expertise
20+ years in Named Patient and Compassionate Use programs.
Global Network
Vetted manufacturers and end-to-end cold-chain logistics.
Full Compliance
Compliant with CDSCO, EMA, FDA, and other global authorities.
Frequently Asked Questions
Everything you need to know.